AZD-9819
Modify Date: 2025-08-29 22:56:14
AZD-9819 structure
|
Common Name | AZD-9819 | ||
|---|---|---|---|---|
| CAS Number | 956907-23-6 | Molecular Weight | 492.453 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C25H19F3N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AZD-9819AZD-9819 is an inhibitor of human neutrophil elastase for potential treatment of chronic obstructive pulmonary disease. COPD Phase 1 Discontinued |
| Name | Azd-9819 |
|---|---|
| Synonym | More Synonyms |
| Description | AZD-9819 is an inhibitor of human neutrophil elastase for potential treatment of chronic obstructive pulmonary disease. COPD Phase 1 Discontinued |
|---|---|
| References | References 1. Gu C, et al. Drug Metab Dispos. 2015 Oct;43(10):1441-9. View Related Products by Target Elastase COPD |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C25H19F3N6O2 |
| Molecular Weight | 492.453 |
| Exact Mass | 492.152161 |
| LogP | 3.41 |
| Index of Refraction | 1.630 |
| 6-[1-(4-Cyanophenyl)-1H-pyrazol-5-yl]-N-ethyl-5-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-3,4-dihydro-2-pyrazinecarboxamide |
| Azd-9819 |
| 2-Pyrazinecarboxamide, 6-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-N-ethyl-3,4-dihydro-5-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]- |